Diabetic

In diabetics, wounds tend to progress quickly and heal slowly. Researchers have used electricity to heal diabetic wounds three times faster, which offers great potential for treating those with diseases that lead to reduced wound healing.

A phase 2 clinical trial is currently exploring a new technique to slow the progression of type 2 diabetes. The simple outpatient surgery can be conducted in the early stages of diagnosis and delay the need for insulin shots.

With the incidence of type 2 diabetes on the rise, science is looking to genetics for answers. A new study has isolated a gene not previously associated with the disease that appears to impair insulin production in type 2 diabetics.

An international team of scientists has found a way to regenerate kidneys damaged by disease, restoring function and preventing kidney failure. The discovery could help improve treatments for complications stemming from diabetes and other diseases.

Type 2 diabetes can take years to develop, but caught early is an entirely preventable disease. A new study is suggesting a particular blood biomarker could be used to identify those on the way to diabetes but yet to display symptoms of disease.

A new study has found people with elevated blood levels of a protein called prostasin face a significantly higher risk of developing diabetes or dying from cancer. It’s unclear at this point whether the protein plays a causal role in either disease.

A study has homed in on a newly discovered mechanism that could prevent insulin resistance in type 2 diabetics. The research found disrupting the expression of a certain protein could protect beta cells and prevent patients from becoming insulin resistant.

Australian scientists have demonstrated a new way to restore insulin production in pancreatic cells, using a drug that’s already approved for use in humans. The study could mark a major breakthrough towards new treatments for diabetes.

Scientists have now identified a cellular pathway that can contribute to the death of insulin-producing cells. They found that blocking it in mice and human cells keeps the beta cells alive for longer, delaying or preventing the onset of diabetes.

Scientists at the University of Cambridge have been developing artificial pancreas technology to help manage diabetes for more than a decade and have now reported "life-changing" results from trials in young children.

A peptide called MOTS-c shows promise in preventing type 1 diabetes, in new tests in human cells in culture and live mice. The peptide regulates the immune system, potentially leading to treatments for type 1 diabetes and other autoimmune diseases.

An artificial pancreas has been trialed in patients with type 2 diabetes for the first time. The device monitors a person’s blood glucose levels and automatically administers insulin when needed – and the results so far are promising.